AUTL - Autolus Therapeutics GAAP EPS of -$1.20 misses by $0.10 revenue of $1.69M misses by $0.01M
2024-03-14 07:02:41 ET
More on Autolus Therapeutics
- BioNTech Buys Into Autolus' Cell Therapy Tech - Why I Expect A Full Acquisition In Time
- Autolus Upgrades Leadership And Faces CAR-T Approval
- SA Analysts Comment On FDA Seeking Boxed Warning For CAR-T Cancer Therapies, Related Impact On AUTL
- Autolus Therapeutics FY 2023 Earnings Preview
- Autolus prices underwritten offering to raise $350M to fund development of obe-cel program